Literature DB >> 2289319

Attitudes of parents of cystic fibrosis children towards neonatal screening and antenatal diagnosis.

L N al-Jader1, M C Goodchild, H C Ryley, P S Harper.   

Abstract

Information on parents' attitudes towards neonatal screening for cystic fibrosis (CF) and antenatal diagnosis by chorion villus biopsy (CVS) has been derived from a detailed questionnaire administered to parents of CF babies diagnosed early following newborn screening (18 babies), and later on account of clinical criteria (11 babies). Screening was by measurement of immunoreactive trypsin (IRT) on Guthrie card blood spots, which was the basis of the Wales/West Midlands IRT Screening Survey, 1985-1989. Families questioned were from Wales. Most parents supported screening: parents of 15/18 (83%) screened babies and 10/11 (91%) unscreened babies. Following antenatal diagnosis, 15/29 (52%) of families would abort a CF foetus. Neither standard of education nor social class correlated with attitudes to screening or antenatal diagnosis, although these factors were related to the parents' knowledge of CF in general. Several families emphasised the importance of minimal delay between the initial mention of the possibility of CF on IRT testing and confirmation (or otherwise) of the diagnosis. Four mothers acknowledge temporary rejection of their babies during the period of uncertainty or following the procedures of diagnosis, emphasising that neonatal screening for CF can have a psychological impact on the parent-child bonding. Although most families supported neonatal screening for CF, this study underlines some of the difficulties which may be encountered during the procedure of screening for CF by IRT.

Entities:  

Keywords:  Empirical Approach; Genetics and Reproduction

Mesh:

Substances:

Year:  1990        PMID: 2289319     DOI: 10.1111/j.1399-0004.1990.tb03613.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  19 in total

1.  Attitudes toward cystic fibrosis carrier and prenatal testing and utilization of carrier testing among relatives of individuals with cystic fibrosis.

Authors:  DeeDee Lafayette; Dianne Abuelo; Mary Ann Passero; Umadevi Tantravahi
Journal:  J Genet Couns       Date:  1999-02       Impact factor: 2.537

2.  Attitudes toward genetic testing for cystic fibrosis among college students.

Authors:  Ran Neiger; Dianne N Abuelo; Mary Ann Passero
Journal:  J Genet Couns       Date:  1992-09       Impact factor: 2.537

Review 3.  Neonatal screening--should we or shouldn't we?

Authors:  P H Weller; J V West
Journal:  J R Soc Med       Date:  1991       Impact factor: 5.344

Review 4.  Newborn screening: new developments, new dilemmas.

Authors:  N J Kerruish; S P Robertson
Journal:  J Med Ethics       Date:  2005-07       Impact factor: 2.903

5.  Attitudes towards prenatal diagnosis and carrier screening for cystic fibrosis among the parents of patients in a paediatric cystic fibrosis clinic.

Authors:  E K Watson; J Marchant; A Bush; B Williamson
Journal:  J Med Genet       Date:  1992-07       Impact factor: 6.318

6.  Considering consent: a structural equation modelling analysis of factors influencing decisional quality when accepting newborn screening.

Authors:  Stuart G Nicholls; Kevin W Southern
Journal:  J Inherit Metab Dis       Date:  2013-09-17       Impact factor: 4.982

7.  Newborn screening for Duchenne muscular dystrophy: a psychosocial study.

Authors:  E P Parsons; A J Clarke; K Hood; E Lycett; D M Bradley
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-03       Impact factor: 5.747

8.  Influence of five years of antenatal screening on the paediatric cystic fibrosis population in one region.

Authors:  S Cunningham; T Marshall
Journal:  Arch Dis Child       Date:  1998-04       Impact factor: 3.791

9.  Reproductive attitudes of couples having a child with cystic fibrosis in Brittany (France).

Authors:  Marc De Braekeleer; Gilles Rault; Gil Bellis
Journal:  J Hum Genet       Date:  2004-04-23       Impact factor: 3.172

10.  Neonatal screening for cystic fibrosis: France rises to the challenge.

Authors:  J P Farriaux; M Vidailhet; M L Briard; V Belot; J L Dhondt
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.